Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
AIDS Research and Human Retroviruses
|
November 16, 2017
Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire
Aaron Christensen-Quick, Christophe Vanpouille, Andrea Lisco, et al.
Viruses
|
May 17, 2017
Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6⁺CD4⁺ T Cells
Mark K Lafferty, Lingling Sun, Aaron Christensen-Quick, et al.
Journal of Virology
|
June 24, 2016
Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection
Aaron Christensen-Quick, Mark Lafferty, Lingling Sun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 8, 2018
Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy
Aaron Christensen-Quick, Antoine Chaillon, Christina Yek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 11, 2019
Effect of Cannabis Use on Human Immunodeficiency Virus DNA During Suppressive Antiretroviral Therapy
Antoine Chaillon, Masato Nakazawa, Christy Anderson, et al.
Clinical Immunology (Orlando, Fla.)
|
February 10, 2015
Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ
Brian Astry, Shivaprasad H Venkatesha, Arian Laurence, et al.
Journal of Virology
|
April 26, 2019
Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy
Aaron Christensen-Quick, Marta Massanella, Andrew Frick, et al.
Science (New York, N.Y.)
|
April 4, 2020
Seeking career clarity
Chloe Antoniou, Katie Burnette, Aaron Christensen-Quick, et al.
NPJ Vaccines
|
October 15, 2021
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
Viviane M Andrade, Aaron Christensen-Quick, Joseph Agnes, et al.
The Journal of Infectious Diseases
|
January 26, 2022
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial
Kimberly A Kraynyak, Elliott Blackwood, Joseph Agnes, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
AIDS Research and Human Retroviruses
|
November 16, 2017
Cytomegalovirus and HIV Persistence: Pouring Gas on the Fire
Aaron Christensen-Quick, Christophe Vanpouille, Andrea Lisco, et al.
Viruses
|
May 17, 2017
Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6⁺CD4⁺ T Cells
Mark K Lafferty, Lingling Sun, Aaron Christensen-Quick, et al.
Journal of Virology
|
June 24, 2016
Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection
Aaron Christensen-Quick, Mark Lafferty, Lingling Sun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 8, 2018
Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy
Aaron Christensen-Quick, Antoine Chaillon, Christina Yek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 11, 2019
Effect of Cannabis Use on Human Immunodeficiency Virus DNA During Suppressive Antiretroviral Therapy
Antoine Chaillon, Masato Nakazawa, Christy Anderson, et al.
Clinical Immunology (Orlando, Fla.)
|
February 10, 2015
Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ
Brian Astry, Shivaprasad H Venkatesha, Arian Laurence, et al.
Journal of Virology
|
April 26, 2019
Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy
Aaron Christensen-Quick, Marta Massanella, Andrew Frick, et al.
Science (New York, N.Y.)
|
April 4, 2020
Seeking career clarity
Chloe Antoniou, Katie Burnette, Aaron Christensen-Quick, et al.
NPJ Vaccines
|
October 15, 2021
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants
Viviane M Andrade, Aaron Christensen-Quick, Joseph Agnes, et al.
The Journal of Infectious Diseases
|
January 26, 2022
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial
Kimberly A Kraynyak, Elliott Blackwood, Joseph Agnes, et al.
Page
of 2